Patent ID: 7960372
Filing Date: 2011-06-14
Classification: A61K,A61P,C07D

Abstract:
1. The compound having Formula II: wherein: A A V and V′ are independently selected from the group consisting of N, CH and O; W and W′ are independently selected from the group consisting of CH and N; X and X′ are independently C Y and Y′ are independently selected from the group consisting of CONR D and D′ are independently selected from the group consisting of alkylenyl and (CR J and J′ are independently selected from the group consisting of alkylenyl and (CR T and T′ are independently selected from the group consisting of C═O, C═S, C═NR U and U′ are independently selected from the group consisting of hydrogen, NR n, m, p and q are independently 0-5; each R each R R Z is a linker covalently linking one of A or pharmaceutically acceptable salts.